Rare diseases
Investigational molecules
Locations
Via Giuseppe Massarenti 9, 40138 Bologna, Italy
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scienti in Bologna, Italy specialises in clinical trials of conditions such as Cardiac amyloidosis, Chronic left ventricular failure, Myelofibrosis, and other specialisations. This site conducts important research.
The Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scienti conducts focused research on cardiovascular diseases, aiming to improve treatment options for patients with serious heart conditions. Current studies assess new therapeutic agents to reduce disease progression and enhance quality of life.
With two active trials overseen by a team of two investigators, the department in Bologna, Italy is evaluating novel drugs to lower biomarkers such as NT‑proBNP and to prevent cardiovascular death and recurrent events. These efforts reflect a commitment to advancing care for individuals living with advanced cardiac disease.
Clinical trials currently enrolling participants at this site.
Study on Vericiguat for Children with Heart Failure Due to Left Ventricular Systolic Dysfunction
ItalyStudy on the Effectiveness and Safety of Eplontersen for Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
ItalyStudy on Extended Access to Momelotinib for Patients with Myelofibrosis
ItalyGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
